Canine Cancer
AKC Canine Health Foundation Canine Cancer Research
Since 1995, CHF and its donors have funded over $17 million in canine cancer research. These 257 research grants have helped scientists study cancer at the cellular level, providing breakthroughs that allow veterinarians to diagnose cancer earlier and treat it more effectively. CHF-funded research also has a One Health impact, extending beyond dogs with an application to human cancer diagnosis and treatment.
Canine cancer research is a major concern of dog owners and veterinary professionals. Typically, about one quarter of CHF’s grant funding concerns various types of canine cancers.
View our Cancer Research Portfolio
Resources
Canine Cancer Articles
Liposomal Clondronate as a Treatment for Malignant Histiocytosis February 1, 2012
Because of its devastating effects on a number of highly loved dog breeds, the AKC Canine Health Foundation sponsors a great deal of research on the diagnosis and treatment of malignant histiocytosis. One such study, initiated by scientists at Colorado State University, has identified a potentially useful new therapeutic option – liposomal clondronate.
Malignant Histiocytosis - Counting Copies January 23, 2012
By looking for DNA copy number aberrations in dogs with histiocytic cancers – genes that express abnormally few or far too many copies – researchers have begun to identify some of the genetic factors that may be putting dogs, and people, at risk.
CHF and GRF to Fund $1 million in Canine Cancer Research September 23, 2011
The AKC Canine Health Foundation (CHF) and Golden Retriever Foundation (GRF) are pleased to announce their joint venture to equally fund up to $1 million in canine cancer research by 2013.
Canine Cancer Updates Presented at National Parent Club Canine Health Conference September 14, 2011
Several CHF funded researchers presented their latest advancements in canine cancer research at the National Parent Club Canine Health Conference on August 12-14, 2011.
Immunotherapy for Canine Meningioma September 12, 2011
Historically, the survival time of dogs with meningiomas treated with surgery alone has been four and one-half to seven months. Systemic therapies so far have had limited effectiveness. However, based on preclinical data from our research program,we embarked on the development of anti-tumor vaccinations to treat dogs with spontaneous meningiomas after surgical removal.
Resources Available for Download
Webinars
May 2022 Canine Cancer Webinar Series
Available on a pay per view basis through the AKC Canine College.
Predicting Lymphoma in Dogs, Presented by Dr. Daniel Promislow
Luteinizing Hormone Receptor Activation in Lymphoma and Hemangiosarcoma, Presented by Dr. Michelle Kutzler
Toward Curative Outcomes in Canine Hemangiosarcoma, Presented by Dr. Chand Khanna
LIVE Panel Q&A Session, Presented by Drs. Promislow, Kutzler, and Khanna
A Novel Non-Surgical Option to Preserve Limbs in Canine Osteosarcoma
Original air date: May 25, 2021
Speaker: Joanne Tuohy, DVM, PhD, DACVS
Recent Advances in Cancer Immunotherapy
Original air date: May 2020
Speaker: Steven Dow, DVM, PhD, Diplomate ACVIM (Oncology)
Update on Canine Hemangiosarcoma
Original air date: May 2017
Speaker: Douglas H. Thamm, VMD, DACVIM (Oncology)
Cancer Immunotherapy: Basic Concepts and Strategies for Improving Treatment Outcomes
Original air date: October 2016
Speaker: Douglas H. Thamm, VMD, DACVIM (Oncology)
Lymphoma: The State of This Disease in Dogs and How Epigenetics May Open Future Doors
Original air date: June 2016
Speaker: Jeffrey M. Bryan, DVM, MS, PhD, DACVIM (Oncology)
Podcasts
The Dog Cancer Answers podcast spoke with AKC Chief Veterinary Officer Dr. Jerry Klein about How to Choose a Dog Breeder. Listen for ways to increase the odds of having a healthy puppy, including the importance of AKC Canine Health Foundation funded research.
How You Can Help
Your support means more studies exploring improved diagnostics and new treatment strategies for canine cancer.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
